- Home
- OPTX vs STRO Comparison
OPTX vs STRO Comparison
Compare OPTX & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPTX
- STRO
- Stock Information
- Founded
- OPTX 1981
- STRO 2003
- Country
- OPTX United States
- STRO United States
- Employees
- OPTX N/A
- STRO N/A
- Industry
- OPTX Blank Checks
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OPTX Finance
- STRO Health Care
- Exchange
- OPTX Nasdaq
- STRO Nasdaq
- Market Cap
- OPTX 55.8M
- STRO 50.0M
- IPO Year
- OPTX N/A
- STRO 2018
- Fundamental
- Price
- OPTX $1.43
- STRO $0.73
- Analyst Decision
- OPTX
- STRO Hold
- Analyst Count
- OPTX 0
- STRO 8
- Target Price
- OPTX N/A
- STRO $6.14
- AVG Volume (30 Days)
- OPTX 91.9K
- STRO 2.4M
- Earning Date
- OPTX 05-23-2025
- STRO 05-08-2025
- Dividend Yield
- OPTX N/A
- STRO N/A
- EPS Growth
- OPTX N/A
- STRO N/A
- EPS
- OPTX 0.00
- STRO N/A
- Revenue
- OPTX $29,392,186.00
- STRO $66,434,000.00
- Revenue This Year
- OPTX N/A
- STRO N/A
- Revenue Next Year
- OPTX N/A
- STRO $1.29
- P/E Ratio
- OPTX $871.00
- STRO N/A
- Revenue Growth
- OPTX 4.36
- STRO N/A
- 52 Week Low
- OPTX $0.85
- STRO $0.52
- 52 Week High
- OPTX $8.39
- STRO $5.17
- Technical
- Relative Strength Index (RSI)
- OPTX 49.89
- STRO 42.48
- Support Level
- OPTX $1.43
- STRO $0.80
- Resistance Level
- OPTX $1.55
- STRO $1.11
- Average True Range (ATR)
- OPTX 0.08
- STRO 0.14
- MACD
- OPTX -0.00
- STRO -0.02
- Stochastic Oscillator
- OPTX 13.04
- STRO 2.56
About OPTX Syntec Optics Holdings Inc.
Syntec Optics Holdings Inc is vertically integrated from design and component manufacturing for lens system assembly to imaging module integration for system solutions. Making its tools, molding, and nano machining allows close interaction and recut ability, enabling special techniques to hold tolerances to sub-micron levels. It has steadily developed a variety of other complementary manufacturing techniques to provide a wide suite of horizontal capabilities including thin film deposition coatings, glass molding, polymer molding, tool-making, mechanical manufacturing, and nano machining.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.